Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
CLDI holding history
Calidi Biotherapeutics, Inc. in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDI overviewAll 13F holders of CLDIFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,042
- Value
- $177
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,042 | $177 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,042 | $249 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,042 | $1.22K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,042 | $1.58K | <0.1% | 00.0% | UnchangedConverted for a 1-for-12 split | Holders |
| Q2 2025 | 12,499 | $2.88K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 12,499 | $7.08K | <0.1% | −10.0% | Reduced | Holders |
| Q4 2024 | 12,500 | $14.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 12,500 | $14.2K | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | Holders |
| Q2 2024 | 125,000 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 125,000 | $70.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 125,000 | $188.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 125,000 | $415.6K | 0.2% | +125,000 | New | Holders |